Regulus Btn


Briefcase Shareholder Briefcase
Email Alerts E-Mail Alerts
Download Center Download Library
RSS News Feeds


(NASDAQ:ISIS) as of 4:15 PM ET on 11/19/02008
Last: 12.03 Change: $1.18 down  (8.93%)
Day High: 13.12 Day Low: 12.02


Recent Releases
11/10/08 Isis Reports Financial Results and Highlights for Third Quarter of 2008
11/06/08 Webcast Alert: Isis Pharmaceuticals' Cardiovascular Program Review
11/06/08 Regulus Therapeutics and Collaborators Discover Role of a microRNA in Tumor Angiogenesis
 
Analyst Firm Phone
James Birchenough Barclays Capital   415-274-5393
Debjit Chattopadhyay Boenning & Scattergood, Inc.   610-684-5417
Eric Schmidt Cowen and Co., LLC   646-562-1345
Geraldine O'Keeffe Fortis Securities LLC   31-20 527-9150
Adam Walsh Jefferies & Company   617-342-7857
Joseph Schwartz Leerink Swann & Company   617-918-4575
Alex To Natixis Bleichroeder, Inc.   212-698-3146
Mark Monane Needham & Company   212-705-0346
Edward Tenthoff Piper Jaffray & Co.   212-284-9403
Carol Werther Summer Street Research Partners   617-532-6418
Aaron Reames Wachovia Capital Markets, LLC   617-603-4219

Contact Us
Kristina Lemonidis
Associate Director, Investor Relations

Telephone: 760-603-2331
E-mail: info@isisph.com